TNNT2 and Stroke: Furthermore, the PROSCIS-B study reported a significant positive dose-response relationship across quartiles of hs-cTnT with a composite outcome of recurrent stroke, MI, and all-cause mortality in 562 patients after mild to moderate stroke.11